A novel combined therapy was tested in the present study, aiming to enhance osteocytes’ beneficial response to LMHF mechanical stimulation through Piezo1 activation in regulation of osteoclastogenesis and breast cancer migration. The gene discussed is PIEZO1; the disease is breast cancer.